ATE140480T1 - Menschliches lymph-gewebe in einem wirt mit angegriffenem immunsystem - Google Patents

Menschliches lymph-gewebe in einem wirt mit angegriffenem immunsystem

Info

Publication number
ATE140480T1
ATE140480T1 AT91909374T AT91909374T ATE140480T1 AT E140480 T1 ATE140480 T1 AT E140480T1 AT 91909374 T AT91909374 T AT 91909374T AT 91909374 T AT91909374 T AT 91909374T AT E140480 T1 ATE140480 T1 AT E140480T1
Authority
AT
Austria
Prior art keywords
immune system
host
attacked
human
tissue
Prior art date
Application number
AT91909374T
Other languages
English (en)
Inventor
Susan Mayo
Reiko Namikawa
Hideto Kaneshima
Joseph M Mccune
Original Assignee
Systemix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Systemix Inc filed Critical Systemix Inc
Application granted granted Critical
Publication of ATE140480T1 publication Critical patent/ATE140480T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Husbandry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Surgical Instruments (AREA)
  • Peptides Or Proteins (AREA)
AT91909374T 1990-05-03 1991-04-29 Menschliches lymph-gewebe in einem wirt mit angegriffenem immunsystem ATE140480T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51874890A 1990-05-03 1990-05-03

Publications (1)

Publication Number Publication Date
ATE140480T1 true ATE140480T1 (de) 1996-08-15

Family

ID=24065324

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91909374T ATE140480T1 (de) 1990-05-03 1991-04-29 Menschliches lymph-gewebe in einem wirt mit angegriffenem immunsystem

Country Status (11)

Country Link
US (1) US5411749A (de)
EP (1) EP0481058B1 (de)
JP (1) JPH04507109A (de)
AT (1) ATE140480T1 (de)
AU (1) AU637914B2 (de)
CA (1) CA2063408A1 (de)
DE (1) DE69120890T2 (de)
DK (1) DK0481058T3 (de)
ES (1) ES2090332T3 (de)
GR (1) GR3021382T3 (de)
WO (1) WO1991016910A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849288A (en) * 1990-01-15 1998-12-15 Yeda Research And Development Co. Ltd. Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
US5652373A (en) * 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
DK9091D0 (da) * 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
US5849987A (en) * 1992-06-02 1998-12-15 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5858328A (en) * 1991-06-04 1999-01-12 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5804160A (en) * 1991-06-04 1998-09-08 Yeda Research And Development Co. Ltd Animal model for hepatitis virus infection
DE69229254T2 (de) * 1991-10-30 1999-09-23 Idemitsu Kosan Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von menschlichen Lymphozyten und menschlichen Antikörpern; und so hergestellte Antikörper
US5866757A (en) * 1992-06-02 1999-02-02 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
CA2144314A1 (en) * 1992-09-11 1994-03-31 James M. Wilson Non-human animal with xenograft of on airway populated by human cells
CA2103693A1 (en) * 1993-08-06 1995-02-07 Steven Gallinger Animal model of the human immune system
US5645982A (en) * 1993-08-19 1997-07-08 Systemix, Inc. Method for screening potential therapeutically effective antiviral agents
US5516977A (en) * 1993-12-17 1996-05-14 Systemix, Inc. Xenogeneic tissue implant in ear pinna
US6455756B1 (en) * 1994-08-12 2002-09-24 Novartis Ag Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice
CA2205138A1 (en) * 1994-11-16 1996-05-23 Baxter International Inc. Human antibodies to t-cell receptor peptides and methods for their preparation
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US20020182730A1 (en) * 1995-07-26 2002-12-05 Micheal L. Gruenberg Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease
US5986170A (en) * 1995-11-13 1999-11-16 Corixa Corporation Murine model for human carcinoma
WO1998044788A2 (en) * 1997-04-09 1998-10-15 Chang Lung Ji Animal model for evaluation of vaccines
DK1265928T3 (da) * 2000-01-27 2010-11-15 Medimmune Llc RSV-neutraliserende antistoffer med ultra høj affinitet
EP1259547B1 (de) 2000-03-01 2012-07-11 Medimmune, Inc. Hochwirksame rekombinante antikörper und methode zu deren herstellung
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030134415A1 (en) * 2001-09-19 2003-07-17 Gruenberg Micheal L. Th1 cell adoptive immunotherapy
US20030134341A1 (en) * 2001-09-19 2003-07-17 Medcell Biologics, Llc. Th1 cell adoptive immunotherapy
US20030175272A1 (en) * 2002-03-07 2003-09-18 Medcell Biologics, Inc. Re-activated T-cells for adoptive immunotherapy
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
CA2542232A1 (en) 2003-06-09 2005-01-20 Alnylam Pharmaceuticals, Inc. Method for treating neurodegenerative disease by inhibiting alpha-synuclein
US20060115485A1 (en) * 2004-10-29 2006-06-01 Medimmune, Inc. Methods of preventing and treating RSV infections and related conditions
EP1997830A1 (de) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV-spezifische Bindemoleküle und Mittel zu ihrer Herstellung
US20090291073A1 (en) * 2008-05-20 2009-11-26 Ward Keith W Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
US8349325B2 (en) 2008-12-23 2013-01-08 Abbott Laboratories Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making
DK3056082T3 (en) 2009-10-06 2018-12-17 Regeneron Pharma RE-MODIFIED MICE AND INPUT
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
US20110229921A1 (en) * 2010-03-18 2011-09-22 Abbott Laboratories METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS
WO2011163558A1 (en) 2010-06-25 2011-12-29 Abbott Laboratories Materials and methods for assay of anti-hepatitis c virus (hcv) antibodies
US20120115244A1 (en) 2010-11-09 2012-05-10 Abbott Laboratories Materials and methods for immunoassay of pterins
EP2675271B1 (de) 2011-02-15 2018-06-13 Regeneron Pharmaceuticals, Inc. Humanisierte m-csf-mäuse
US8993248B2 (en) 2011-12-31 2015-03-31 Abbott Laboratories Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use
AU2013312359B8 (en) 2012-09-07 2019-08-15 Institute For Research In Biomedicine (Irb) Genetically modified non-human animals and methods of use thereof
SG11201502685XA (en) 2012-11-05 2015-05-28 Regeneron Pharma Genetically modified non-human animals and methods of use thereof
SG10202002187WA (en) 2014-05-19 2020-04-29 Regeneron Pharma Genetically modified non-human animals expressing human epo
IL302370B2 (en) 2015-04-13 2025-10-01 Regeneron Pharma Mice genetically engineered to express alpha signal modulator protein and interleukin 15 and methods for using them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE119197T1 (de) * 1987-12-23 1995-03-15 Univ Leland Stanford Junior Schimäre immunkompromittierende säugetiere und ihre verwendung.
JP2981486B2 (ja) * 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート 哺乳動物の免疫系研究方法
EP0438053B1 (de) * 1990-01-15 1999-06-16 Yeda Research And Development Company Limited Dauerhafte Verpflanzung und Entwicklung menschlicher hämatopoietischer Zellinien bei normalen Säugetieren
WO1991018615A1 (en) * 1990-05-25 1991-12-12 Systemix, Inc. Human peripheral blood cells in an immunocompromised host
JPH04252128A (ja) * 1990-08-03 1992-09-08 Systemix Inc 免疫化された宿主における変性された異種移植器官系

Also Published As

Publication number Publication date
EP0481058B1 (de) 1996-07-17
AU7858391A (en) 1991-11-27
US5411749A (en) 1995-05-02
AU637914B2 (en) 1993-06-10
GR3021382T3 (en) 1997-01-31
ES2090332T3 (es) 1996-10-16
CA2063408A1 (en) 1991-11-04
EP0481058A1 (de) 1992-04-22
WO1991016910A1 (en) 1991-11-14
JPH04507109A (ja) 1992-12-10
DE69120890T2 (de) 1997-02-20
DE69120890D1 (de) 1996-08-22
DK0481058T3 (da) 1996-12-02
EP0481058A4 (en) 1993-07-14

Similar Documents

Publication Publication Date Title
DE69120890D1 (de) Menschliches lymph-gewebe in einem wirt mit angegriffenem immunsystem
DE69429625D1 (de) Dämpfung eines immundominanten epitops eines antigens zur verwendung für pflanzen, tierische und menschliche impstoffe und immuntherapien
DE68924162D1 (de) Stressproteine und verwendungen dafür.
NO933126D0 (no) Loeselige ligander for cd40
EP0474727A4 (en) Her2 extracellular domain
ATE195875T1 (de) Spezifische modulationen des immunsystems
ATE246513T1 (de) Zubereitungen und verfahren für die behandlung von krebs und hyperproliferierenden krankheiten
DE69233012D1 (de) Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
ATE101648T1 (de) Expression eines tumorspezifischen antigens eines rekombinanten virusvektors sowie dessen anwendung zur versorgenden oder heilenden behandlung des entsprechenden tumors.
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
IT1102400B (it) Vaccino per la immunizzazione degli uccelli ed in particolare del pollame contro la sindrome del calo di deposizione delle uova e procedimento per la produzione del detto vaccino
DK16087D0 (da) Mastitis-vaccine
DE69022980D1 (de) Gesteigerte erzeugung von proteinen in tieren.
IT8026986A0 (it) Antigene di prostata umana purificato e procedimento per preparare anticorpi correlati a tale antigene.
SE7704245L (sv) Medel for profylax och terapi av gastroenterit
SE7901565L (sv) Medel for immunisering
DE3855280D1 (de) Von mca 16-88 erkanntes antigen
ATE138200T1 (de) Das von mca-28a32 erkannte antigen
GR3021983T3 (en) Cross-reactive influenza a immunization
ATE266676T1 (de) Verwendung von aviären, vitellinen, gegen hiv- antigene gerichteten antikörpern zur herstellung pharmazeutischer zubereitungen
ES2109954T3 (es) Estimulacion del crecimiento con anticuerpos antiidiotipicos cultivados contra un anticuerpo a un polipeptido potenciador del crecimiento.
ATE152916T1 (de) Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind
SU1069819A1 (ru) Способ получени антитоксической гипериммунной сыворотки против колибактериоза
Devyataev et al. Selective effect of sensitization on the phenotype of slow and fast skeletal muscle of guinea pig
MAISKII et al. On the effect of antisera against irradiated malignant tissues on the growth of experimental tumors in animals exposed to the irradiation. I. On the antibody-producing capacity of irradiated antigens in various species of animals